Advances in antibody-drug conjugates in the treatment of advanced triple-negative breast cancer: a narrative review
{{output}}
Background and objective: Triple-negative breast cancer (TNBC) is more aggressive when compared with other breast cancer subtypes, and advanced TNBC (aTNBC) has always been a challenge for clinical treatment. In recent years, sig... ...
